167 related articles for article (PubMed ID: 35085590)
21. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract][Full Text] [Related]
22. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
Ma S; Jia W; Ni S
Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
[No Abstract] [Full Text] [Related]
24. miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase-3 by HMGA2.
Qiu K; Xie Q; Jiang S; Lin T
J Clin Lab Anal; 2020 Feb; 34(2):e23044. PubMed ID: 31670857
[TBL] [Abstract][Full Text] [Related]
25. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis.
Li G; Kong Q
Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440
[TBL] [Abstract][Full Text] [Related]
26. CircDLGAP4 induces autophagy and improves endothelial cell dysfunction in atherosclerosis by targeting PTPN4 with miR-134-5p.
Xiong Y; Huang H; Chen F; Tang Y
Environ Toxicol; 2023 Dec; 38(12):2952-2966. PubMed ID: 37615249
[TBL] [Abstract][Full Text] [Related]
27. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G
Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335
[TBL] [Abstract][Full Text] [Related]
28. miR-744-5p mediates lncRNA HOTTIP to regulate the proliferation and apoptosis of papillary thyroid carcinoma cells.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zheng J; Lu X
Exp Cell Res; 2020 Jul; 392(1):112024. PubMed ID: 32335029
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling.
Wang Z; Wang Z; Wang T; Yuan J; Wang X; Zhang Z
Rev Cardiovasc Med; 2019 Sep; 20(3):187-197. PubMed ID: 31601093
[TBL] [Abstract][Full Text] [Related]
30. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.
Hu C; Fu X; Li S; Chen C; Zhao X; Peng J
Daru; 2024 Jun; 32(1):11-24. PubMed ID: 37926762
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis.
Gan J; Liu S; Zhang Y; He L; Bai L; Liao R; Zhao J; Guo M; Jiang W; Li J; Li Q; Mu G; Wu Y; Wang X; Zhang X; Zhou D; Lv H; Wang Z; Zhang Y; Qian C; Feng M; Chen H; Meng Q; Huang X
Exp Mol Med; 2022 Aug; 54(8):1290-1305. PubMed ID: 36042375
[TBL] [Abstract][Full Text] [Related]
32. Dexmedetomidine attenuates acute stress-induced liver injury in rats by regulating the miR-34a-5p/ROS/JNK/p38 signaling pathway.
Li D; Qian J; Li J; Wang J; Liu W; Li Q; Wu D
J Toxicol Sci; 2022; 47(5):169-181. PubMed ID: 35527005
[TBL] [Abstract][Full Text] [Related]
33. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N; Yin D; Lun B; Guo X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
[TBL] [Abstract][Full Text] [Related]
34. MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration.
Yang Y; Xia S; Zhang L; Wang W; Chen L; Zhan W
Cancer Biol Ther; 2020 Jun; 21(6):522-532. PubMed ID: 32151175
[TBL] [Abstract][Full Text] [Related]
35. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
Peng Y; Fang X; Yao H; Zhang Y; Shi J
Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
[No Abstract] [Full Text] [Related]
36. Novel regulation of miR-34a-5p and HOTAIR by the combination of berberine and gefitinib leading to inhibition of EMT in human lung cancer.
Zheng F; Li J; Ma C; Tang X; Tang Q; Wu J; Chai X; Xie J; Yang XB; Hann SS
J Cell Mol Med; 2020 May; 24(10):5578-5592. PubMed ID: 32248643
[TBL] [Abstract][Full Text] [Related]
37. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.
Ma X; Wei J; Zhang L; Deng D; Liu L; Mei X; He X; Tian J
Biomed Pharmacother; 2016 May; 80():220-226. PubMed ID: 27133060
[TBL] [Abstract][Full Text] [Related]
38. [miR-34a-5p regulates viability, invasion and apoptosis of placental trophoblastic cells
Li Q; Xu J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):79-86. PubMed ID: 32376568
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.
Zhu C; Deng X; Wu J; Zhang J; Yang H; Fu S; Zhang Y; Han Y; Zou Y; Chen Z; Lin S
Tumour Biol; 2016 Aug; 37(8):11289-97. PubMed ID: 26951513
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
